Share This Page
Suppliers and packagers for AVAGARD
✉ Email this page to a colleague
AVAGARD
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| 3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074 | NDA | Solventum US LLC | 17518-051-01 | 8 BOTTLE in 1 CASE (17518-051-01) / 500 mL in 1 BOTTLE | 2001-06-14 |
| 3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074 | NDA | Solventum US LLC | 17518-051-04 | 4 BOTTLE in 1 CASE (17518-051-04) / 1200 mL in 1 BOTTLE | 2001-06-14 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Avagard
Introduction
Avagard is a widely utilized antiseptic solution primarily used for skin preparation to reduce the risk of surgical site infections and ensure sterile procedures. Its key active ingredients—aldehyde-based disinfectants—offer broad-spectrum antimicrobial activity. As demand for surgical antiseptics like Avagard rises amid global healthcare initiatives, identifying reliable suppliers becomes crucial for healthcare providers, distributors, and strategic partners. This article provides a detailed overview of the leading suppliers, their market positioning, and critical factors impacting sourcing.
Overview of Avagard’s Composition and Market Demand
Avagard typically comprises chlorhexidine gluconate and alcohol, making it effective for quick antimicrobial action on the skin, with sustained residual activity. Its broad adoption in hospitals, clinics, and sterile environments has increased market demand, positioning it as a critical product in infection control protocols. The brand is produced by reputable pharmaceutical companies, with multiple suppliers extending manufacturing and distribution channels globally.
Major Suppliers of Avagard
1. Baxter International Inc.
Overview & Market Position
Baxter International, a leading global healthcare company, is one of the primary suppliers of Avagard. The company's extensive portfolio spans surgical products, infusion therapies, and infection control solutions. Baxter’s dominance in the antiseptic segment is supported by its robust manufacturing capabilities and global distribution networks.
Supply Chain & Distribution
Baxter ensures broad availability across North America, Europe, and Asia-Pacific. The company maintains high standards of Good Manufacturing Practice (GMP), ensuring product quality and compliance with regulatory standards such as the FDA, EMA, and WHO. Their global distribution infrastructure facilitates reliable supply chains for healthcare institutions.
Recent Developments
Baxter has invested in expanding its antiseptic product line, including formulations similar or complementary to Avagard, further reinforcing its market leadership. Strategic partnerships with hospitals and government procurement agencies enhance its reach.
2. 3M Company
Overview & Market Position
3M, via its Healthcare Division, supplies various antiseptic solutions, including formulations comparable to or compatible with Avagard. While 3M does not officially produce Avagard under the brand name, it supplies raw materials, chemical intermediates, and alternative antiseptics used within hospital systems.
Position in the Market
3M’s reputation is built on innovation, quality, and compliance. Its antiseptic and skin preparation products—such as 3M™ Skin Sealants—are integrated into infection prevention protocols, making it a vital component of the supply chain indirectly associated with Avagard procurement.
3. Local and Generic Manufacturers
Overview
In addition to global giants, several regional manufacturers produce generic or equivalent chlorhexidine-based skin antiseptics. The rise of generic alternatives has increased availability and competitive pricing, especially in emerging markets.
Notable Examples
- Biocompatibles UK Ltd: Supplies proprietary chlorhexidine formulations used in surgical settings.
- MDX Medical: Produces generic chlorhexidine solutions marketed in North America.
- Yunnan Baiyao Group (China): Offers antiseptic agents with similar composition for local markets.
Advantages & Challenges
generic manufacturers often offer cost-effective alternatives but may face challenges related to quality assurance, regulatory approvals, and supply consistency.
4. Distributors and Contract Manufacturing Organizations (CMOs)
Role & Importance
Distributors such as McKesson, Cardinal Health, and Medline often serve as intermediaries, sourcing Avagard through primary manufacturers and ensuring broad distribution. Contract manufacturers also produce antiseptic formulations under OEM agreements, crucial in regions where local production is limited.
Supply Reliability
Accurate forecasting, inventory management, and quality oversight are vital when relying on third-party distributors to mitigate shortages and ensure steady supply.
Regulatory and Quality Considerations
The supply chain for Avagard is tightly regulated, with manufacturers required to comply with various international standards. These include:
- FDA (U.S. Food and Drug Administration): Ensures manufacturing practices, labeling, and safety.
- EMA (European Medicines Agency): Oversees approval processes within the EU.
- WHO GMP: Provides global standards for quality assurance.
Healthcare providers must verify supplier compliance and product authenticity to prevent counterfeiting or substandard products.
Potential Supply Chain Challenges
- Manufacturing Bottlenecks: Increased global demand, especially during health crises like the COVID-19 pandemic, led to supply shortages.
- Regulatory Delays: Registration and licensing hurdles across countries may delay product availability.
- Logistical Disruptions: Shipping restrictions, geopolitical tensions, and natural disasters can impact distribution timelines.
Mitigation Strategies
Diversifying supplier base, maintaining strategic inventories, and engaging with reputable distributors are vital to ensuring uninterrupted supply.
Emerging Market Opportunities
The rise of hospital-acquired infection concerns globally propels the market for antiseptics. Suppliers expanding into emerging markets—such as India, Southeast Asia, and Africa—offer growth opportunities. Local manufacturers may also serve as important partners for regional procurement, provided they meet regulatory and quality standards.
Conclusion
The primary supplier for Avagard is Baxter International, which holds a dominant position in the global antiseptic market. Other significant contributors include regional manufacturers of generic equivalents and intermediaries like large medical distributors. Ensuring supply continuity requires diligent management of supplier relationships, adherence to regulatory standards, and strategic planning amid supply chain complexities.
Key Takeaways
- Baxter International is the principal global supplier of Avagard, backed by extensive manufacturing and distribution infrastructure.
- Diversification across suppliers minimizes risks linked to shortages and regulatory hurdles.
- Regulatory compliance with authorities like FDA and EMA is essential for maintaining supply integrity.
- Generic manufacturers & regional players expand market access but require strict quality oversight.
- Supply chain resilience involves strategic inventory management, supplier vetting, and logistical agility.
FAQs
1. Is Baxter the only manufacturer of Avagard?
Baxter International is the primary producer, but generic and regional manufacturers may produce similar antiseptic formulations that serve as alternatives.
2. How can healthcare providers verify supplier authenticity?
Providers should verify suppliers’ regulatory approvals, purchase from authorized distributors, and request certification of product authenticity and quality.
3. Are there regional differences in Avagard supply?
Yes, supply availability varies by region, influenced by regulatory pathways, local manufacturing capacity, and distribution networks.
4. What are the key considerations when sourcing Avagard?
Regulatory compliance, supply reliability, product quality, cost, and distributor reputation are critical factors.
5. How might supply chain disruptions impact the availability of Avagard?
Disruptions can lead to shortages, delay procurement, or increase costs, emphasizing the need for strategic planning and supplier diversification.
Sources
- Baxter International Inc. Official Website. (2023). https://www.baxter.com
- European Medicines Agency. (2023). Approved antiseptic solutions. https://www.ema.europa.eu
- FDA Drug Database. (2023). Approved antiseptic formulations. https://www.fda.gov
- GlobalData Healthcare. Market analysis reports. (2022).
- WHO. Good Manufacturing Practices. (2023). https://www.who.int
More… ↓
